Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We carried out a randomized, double-blind, placebo-controlled trial of hyperbaric oxygen therapy (HBO) in patients with chronic stable MS. Eighty-two patients were treated in a multiplace hyperbaric chamber with gas supplied by mask. Forty-one patients received 20 consecutive daily treatments of 100% O2 followed by 7 "booster" treatments in the next 6 months; 41 control patients received "air" (12.5% O2 at 1.75 atmospheres absolute). There was no significant difference in treatment and control groups in the Extended Kurtzke Disability scores, Kurtzke Functional scores, magnetic resonance imaging, or evoked potentials after the initial 20 treatments or after the boosters. HBO is not effective in treating chronic stable MS.

Type

Journal article

Journal

Neurology

Publication Date

07/1986

Volume

36

Pages

988 - 991

Keywords

Adult, Aged, Chronic Disease, Clinical Trials as Topic, Double-Blind Method, Evoked Potentials, Auditory, Evoked Potentials, Visual, Humans, Hyperbaric Oxygenation, Magnetic Resonance Spectroscopy, Middle Aged, Multiple Sclerosis, Random Allocation